Journals / Bağcılar Tıp Bülteni / 2021 / Cilt: 6 - Sayı: 2

Multiple Primary Tumors of the GastrointestinalTract: Our Six-year Results

Gastrointestinal Sistemin Çoklu Primer Tümörleri: Altı Yıllık Sonuçlarımız

Pages
148–156
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Multiple primary tumors (MPTs) are tumors that develop simultaneously or at different times in the same or different organs.
📊
Key Findings & Data:Genetic instability, gene mutation, immunodeficiency, prolongation of life span with chemotherapy, radiotherapy and target treatments are among the reasons that increase the development of the second primary tumor.
💡
Conclusion & Impact:Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.
🔬Design:Research Article
📍Scope:2014 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Multiple primary tumors (MPTs) are tumors that develop simultaneously or at different times in the same or different organs. They are divided into two groups as synchronous and metachronous tumors. Genetic instability, gene mutation, immunodeficiency, prolongation of life span with chemotherapy, radiotherapy and target treatments are among the reasons that increase the development of the second primary tumor. In our study, we aimed to present cases with MPTs accompanying gastrointestinal system (GIS) tumors with clinicopathological features.Method: The cases having the criteria of MPT among the cases diagnosed with primary tumor discussed in the GIS councils of our hospital between 2014 and 2019 were included in our study. Results: A total of 162 cases (4.7%) with a diagnosis of MPT were detected. While 52 of the cases were in the synchronous tumor group and 110 were in the metachronous tumor group. Most of the patients in both groups were male (59.9%). The most common MPT groups observed in men were left colon-prostate and rectum-right colon tumors, and stomach-breast and left colon-breast tumors in women. The second primary tumors accompanying GIS tumors in the synchronous and metachronous tumor groups belonged to the GIS and urogenital system. Survival rates were lower in cases with metachronous tumors than in cases with synchronous tumors, but the intergroup difference was not statistically significant. The survival rate in cases of GIS malignancy originating from the stomach was lower compared to cases with other GIS malignancies with a statistically significant difference. Conclusion: In terms of GIS tumors, prostate and colon tumors in men and breast tumors in women may be risk factors for the development of MPTs.

Özet

Amaç: Çoklu primer tümörler (ÇPT) eş zamanlı ya da farklı zamanda aynıya da farklı organlarda gelişen tümörlerdir. Senkron ve metakron tümörolarak iki gruba ayrılmaktadırlar. Genetik instabilite, gen mutasyonu,immün yetmezlik, kemoterapi, radyoterapi ve hedef tedavileri ile yaşamsüresinin uzaması ikinci primer tümör gelişimini artıran nedenler arasındasayılmaktadır. Çalışmamızda gastrointestinal sistem (GİS) tümörleri ilebirliktelik gösteren ÇPT’li olguları klinikopatolojik özellikleriyle birliktesunmayı amaçladık. Yöntem: Çalışmamıza 2014-2019 yılları arasında hastanemiz GİSkonseylerinde tartışılan primer tümör tanısı almış olgular içinden ÇPTkriterleri taşıyan olgular dahil edildi. Bulgular: ÇPT tanılı 162 olgu (%4,7) saptandı. Olguların 52’si senkron,110’u metakron tümör grubundaydı. Her iki grupta olguların çoğu erkekti(%59,9). Erkeklerde en sık izlenen çoklu primer tümör grubu sol kolon prostat ve rektum-sağ kolon iken, kadınlarda mide-meme ve sol kolon memeydi. Senkron ve metakron tümör grubunda GİS tümörlerine eşlikeden ikinci primer tümörler GİS ve ürogenital sisteme aitti. Sağkalımoranları metakron tümörlü olgularda senkron tümörlü olgulara göre dahadüşük saptandı, ancak aradaki fark istatistiksel olarak anlamlı değildi. GİSmalignitesi mide kaynaklı olgularda sağkalım oranı, diğer GİS malignitesiolan olgularla karşılaştırıldığında daha düşüktü ve istatistiksel olarakanlamlıydı. Sonuç: GİS tümörleri açısından erkeklerde prostat ve kolon, kadınlardaise meme tümörleri ÇPT gelişimi için risk faktörü olabilir.

🔖

Cite This Article

ERHAN, S. Ş., ALEMDAR, A., DİNÇER, S. T., UYSAL, E. (2022). Multiple Primary Tumors of the GastrointestinalTract: Our Six-year Results. Bağcılar Tıp Bülteni, Cilt: 6 - Sayı: 2, 148–156. https://ajindex.com/articles/458942

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Warren S, Gates O. Multiple primary malignant tumors: A survey of the literature and statistical study. Am J Cancer 1932;9(16):1358- 1414
  2. Campbell LV, Watne AL. Multiple primary malignant neoplasms. Arch Surg 1969;99(3):401-405
  3. Mehdi I, Shah AH, Moona MS, Verma K, Abussa A, Elramih R, et al. Synchronous and metachronous malignant tumours expect the unexpected. J Pak Med Assoc 2010;60(11):905-909
  4. Liu z, Liu C, Guo W, Li S, Bai O. Clinical analysis of 152 cases of multipl primary malignant tumors in 15,398 patients with malignant tumors. Plos One 2015;10(5):e0125754. doi: 10.1371/ journal.pone.0125754
  5. Lv M, Zhang X, Shen Y, Wang F, Yang J, Wang B, et al. Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors. Medicine (Baltimore) 2017;96(17):e6799. doi: 10.1097/MD.0000000000006799
  6. Doğu GG, Yaren A, Taşköylü BY, İşler K, Değirmencioğlu S. Synchronous and metachronous double primary cancer patients: Single center experience. Pamukkale Medical Journal 2012;5(1):1- 4
  7. Aydıner A, Karadeniz A, Uygun K, Tas S, Tas F, Disci R, et al. Multiple primary neoplasms at a single institution: Differences between synchronous and metachronous neoplasms. Am J Clin Oncol 2000;23(4):364-370
  8. Demandante CGN, Troyer DA, Miles TP. Multiple primary malignant neoplasms case report and a comprehensive review of the literature. Am J Clin Oncol 2003;26(1):79-83
  9. Engin K. Cancers in multipl primary sites. Int Surg 1994;79(1):33- 37
  10. Ikubo A, Matsufuji S, Morifuji Y, Koga H, Kobarai T, Kouya N, et al. Clinical features, prognosis, diagnostic approaches and treatment of multipl primary malignancies in the digestive system. Anticancer Res 2019;39(12):6863-6870
  11. Shah BK, Khanal A, Hewett Y. Second primary malignancies in adults with gastric cancer-A US population-based study. Front Oncol 2016;6(82):1-4
  12. Motuzyuk I, Sydorchuk O, Kovtun N, Palian Z, Kostiuchenko Y. Analysis of trends and factors in breast multiple primary malignant neoplasms. Breast Cancer 2018;12: 1178223418759959. doi: 10.1177/1178223418759959 13. Lawniczak M, Gawin A, Jaroszewicz-Heigelmann H, RogozaMateja W, Raszeja-Wyszormirska J, Bialek A, et al. Synchronous and metachronous neoplasms in gastric cancer patients: A 23-year study. W J Gastroenterol 2014;20(23):7480-7487
  13. Ballester V, Cruz-Correa M. How and when to consider genetic testing for colon cancer? Gastroenterol 2018;155(4):955-959
  14. Hayat MJ, Howlader N, Reichman ME, Edw